Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Klement

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cellular Immunology|December 22, 2020
MS4A1 expression and function in T cells in the colorectal cancer tumor microenvironmentT William Mudd, Chunwan Lu, John D Klement, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2018
IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor CellsWei Xiao, John D Klement, Chunwan Lu, et al.
Cellular Immunology|June 22, 2021
Expression regulation and function of PD-1 and PD-L1 in T lymphoma cellsMaria Y Liu, John D Klement, Candace J Langan, et al.
Cancers|November 18, 2020
Osteopontin: A Key Regulator of Tumor Progression and ImmunomodulationHannah R Moorman, Dakota Poschel, John D Klement, et al.
Immunology Letters|June 26, 2024
In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockadePriscilla S Redd, Alyssa D Merting, John D Klement, et al.
Cancer Letters|February 17, 2020
SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growthChunwan Lu, John D Klement, Dafeng Yang, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2020
Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cellsMohammed L Ibrahim, Chunwan Lu, John D Klement, et al.
Cancers|March 6, 2021
Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor ProgressionJohn D Klement, Dakota B Poschel, Chunwan Lu, et al.
Oncoimmunology|September 20, 2018
H3K4me3 mediates the NF-κB p50 homodimer binding to the <i>pdcd1</i> promoter to activate PD-1 transcription in T cellsPriscilla S Redd, Chunwan Lu, John D Klement, et al.
Journal for Immunotherapy of Cancer|June 24, 2019
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytesChunwan Lu, John D Klement, Mohammed L Ibrahim, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cellular Immunology|December 22, 2020
MS4A1 expression and function in T cells in the colorectal cancer tumor microenvironmentT William Mudd, Chunwan Lu, John D Klement, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2018
IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor CellsWei Xiao, John D Klement, Chunwan Lu, et al.
Cellular Immunology|June 22, 2021
Expression regulation and function of PD-1 and PD-L1 in T lymphoma cellsMaria Y Liu, John D Klement, Candace J Langan, et al.
Cancers|November 18, 2020
Osteopontin: A Key Regulator of Tumor Progression and ImmunomodulationHannah R Moorman, Dakota Poschel, John D Klement, et al.
Immunology Letters|June 26, 2024
In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockadePriscilla S Redd, Alyssa D Merting, John D Klement, et al.
Cancer Letters|February 17, 2020
SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growthChunwan Lu, John D Klement, Dafeng Yang, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2020
Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cellsMohammed L Ibrahim, Chunwan Lu, John D Klement, et al.
Cancers|March 6, 2021
Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor ProgressionJohn D Klement, Dakota B Poschel, Chunwan Lu, et al.
Oncoimmunology|September 20, 2018
H3K4me3 mediates the NF-κB p50 homodimer binding to the <i>pdcd1</i> promoter to activate PD-1 transcription in T cellsPriscilla S Redd, Chunwan Lu, John D Klement, et al.
Journal for Immunotherapy of Cancer|June 24, 2019
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytesChunwan Lu, John D Klement, Mohammed L Ibrahim, et al.
Pageof 3